AAAAAA

   
Results: 1-11 |
Results: 11
Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3 '-untranslated region
Authors: Durbin, AP Karron, RA Sun, W Vaughn, DW Reynolds, MJ Perreault, JR Thumar, B Men, R Lai, CJ Elkins, WR Chanock, RM Murphy, BR Whitehead, SS
Citation: Ap. Durbin et al., Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3 '-untranslated region, AM J TROP M, 65(5), 2001, pp. 405-413
A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission fromvaccinees to mosquitoes
Authors: Troyer, JM Hanley, KA Whitehead, SS Strickman, D Karron, RA Durbin, AP Murphy, BR
Citation: Jm. Troyer et al., A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission fromvaccinees to mosquitoes, AM J TROP M, 65(5), 2001, pp. 414-419
African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1,-2, and-3 infection
Authors: Durbin, AP Elkins, WR Murphy, BR
Citation: Ap. Durbin et al., African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1,-2, and-3 infection, VACCINE, 18(22), 2000, pp. 2462-2469
A live attenuated recombinant chimeric parainfluenza virus (PIV) candidatevaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3
Authors: Tao, T Davoodi, F Cho, CJ Skiadopoulos, MH Durbin, AP Collins, PL Murphy, BR
Citation: T. Tao et al., A live attenuated recombinant chimeric parainfluenza virus (PIV) candidatevaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3, VACCINE, 18(14), 2000, pp. 1359-1366
Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes
Authors: Skiadopoulos, MH Surman, SR Durbin, AP Collins, PL Murphy, BR
Citation: Mh. Skiadopoulos et al., Long nucleotide insertions between the HN and L protein coding regions of human parainfluenza virus type 3 yield viruses with temperature-sensitive and attenuation phenotypes, VIROLOGY, 272(1), 2000, pp. 225-234
A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is at attenuated in primates
Authors: Bailly, JE McAuliffe, JM Durbin, AP Elkins, WR Collins, PL Murphy, BR
Citation: Je. Bailly et al., A recombinant human parainfluenza virus type 3 (PIV3) in which the nucleocapsid N protein has been replaced by that of bovine PIV3 is at attenuated in primates, J VIROLOGY, 74(7), 2000, pp. 3188-3195
Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy
Authors: Durbin, AP Skiadopoulos, MH McAuliffe, JM Riggs, JM Surman, SR Collins, PL Murphy, BR
Citation: Ap. Durbin et al., Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy, J VIROLOGY, 74(15), 2000, pp. 6821-6831
A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge
Authors: Tao, T Skiadopoulos, MH Durbin, AP Davoodi, F Collins, PL Murphy, BR
Citation: T. Tao et al., A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge, VACCINE, 17(9-10), 1999, pp. 1100-1108
Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates
Authors: Durbin, AP McAuliffe, JM Collins, PL Murphy, BR
Citation: Ap. Durbin et al., Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates, VIROLOGY, 261(2), 1999, pp. 319-330
Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine
Authors: Skiadopoulos, MH Surman, S Tatem, JM Paschalis, M Wu, SL Udem, SA Durbin, AP Collins, PL Murphy, BR
Citation: Mh. Skiadopoulos et al., Identification of mutations contributing to the temperature-sensitive, cold-adapted, and attenuation phenotypes of the live-attenuated cold-passage 45 (cp45) human parainfluenza virus 3 candidate vaccine, J VIROLOGY, 73(2), 1999, pp. 1374-1381
Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies
Authors: Durbin, AP Cho, CJ Elkins, WR Wyatt, LS Moss, B Murphy, BR
Citation: Ap. Durbin et al., Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies, J INFEC DIS, 179(6), 1999, pp. 1345-1351
Risultati: 1-11 |